Healthcare101

  Lateral Flow Assays Market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029 according to a new report by MarketsandMarkets™. The rising demand of lateral flow assays due to increasing number of geriatric populations, growing prevalence of infectious diseases as well as increasing of point of care tests are some of the key factors that are driving the growth of this market. However, the hesitance in the patients as well as in health professionals to change in the conventional diagnostic method and the lack of accuracy of lateral flow assays are some of the key restraints for lateral flow assays market. Lateral Flow Assays Market Size, Dynamics & Ecosystem Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133 Browse in-depth TOC on "Lateral Flow Assays Market" 420 - Tables 59 - Figures 399 – Pages "Kits ...

  Market Size The global lateral flow assays market is projected to reach USD 16.8 billion by 2029 from USD 10.8  billion in 2023.  The Lateral Flow Assay (LFA) market is experiencing significant growth, driven by the increasing demand for point-of-care diagnostics and the rising prevalence of infectious diseases. Lateral flow assays are widely used in various applications, including medical diagnostics, food safety, environmental testing, and drug development. To know about the assumptions considered for the study  download the pdf brochure Several factors contribute to this growth: Point-of-Care Testing Demand : The need for rapid, on-site diagnostic tests is a major driver, particularly in remote and underserved areas. Prevalence of Infectious Diseases : The ongoing need to manage and control outbreaks of diseases such as COVID-19, influenza, and malaria boosts market demand. Technological Advancements : Innovations in LFA technology, including the development of ...